We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival (IMPROVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00742001
Recruitment Status : Terminated (An endpoint difference between 3 energies was not observed. Correlations between recovery and ATP were established, and will be used for a Whole Blood system.)
First Posted : August 27, 2008
Last Update Posted : March 16, 2010
United States Department of Defense
Information provided by:
Terumo BCTbio

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2009
  Study Completion Date : September 2009